MSK Virtual Management of Treatment-Related Adverse Events Symposium
Friday, October 23, 2020 - Saturday, October 24, 2020
CME Provider:
Memorial Sloan Kettering Cancer Center › MSK CME 633 3rd Ave, 12th Floor New York, New York (NY) 10017 United States
Phone: 646-227-2025
Visit the CME Provider Webpage ›
Description:
Live Virtual Experience
We are excited to announce that this course will be delivered as a virtual experience. By registering for the live virtual course, you will be able to view presentations, hear live audio, and interact online.
All sessions presented live on October 23-24, 2020 will be recorded and made available to attendees for viewing after the course. CME and ABIM MOC credit will be offered for this course and a certificate will be available after a post-course evaluation is complete.
This new live virtual course will be fully web-based, so all you will need is a computer, phone, or tablet and an internet connection. Access details will be emailed to all attendees before the course.
Course Overview
Systemic anticancer therapies (cytotoxic chemotherapies, targeted therapies, immunotherapies) have resulted in remarkable improvements in patient survival. Despite this remarkable success, the majority of patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies.
2020 Symposium Highlights:
- Therapy-related adverse events will affect the majority of cancer patients, resulting in increased cost, inconsistent dosing, and decreased quality of life. - With increased survival and patients living longer on therapy, adverse events affecting quality of life and clinical outcome command attention. - Lectures focused on immune-related adverse events will describe the clinical presentation, diagnosis, and management strategies for the oncology healthcare provider. - Up-to-date information will be presented on adverse event mechanisms and management from specialists in the most commonly affected organ systems. - Practical strategies to identify patients at high risk will be highlighted, with strategies to direct patients towards the most efficient therapies based on healthcare providers. - New strategies to monitor and manage symptoms of patients on active anticancer treatment will be discussed including patient-reported outcomes and teleoncology visits.
Visit the CME Course Webpage › View the Course Brochure ›
Instructors:
MSK Course Director:
Mario E. Lacouture, MD
MSK Course Co-Directors:
Shari B. Goldfarb, MD Robert Daly, MD, MBA
CME Credit:
Physicians: 6.75 Hours
Self Assessment Module (SAM):
No
Live Webinar:
Yes
Specialty Audience:
Allergy / Immunology Dermatology Emergency Medicine Family Medicine Internal Medicine Obstetrics / Gynecology Pediatrics
RADLIST Course #23285
|
Map of
Rockefeller Research Laboratories, 430 E 67th Street, New York, New York (NY), United States
|
|
Show Nearby:
Rank By:
|
|
|
|
|
|